Australian Rotavirus Surveillance Program Annual Report, 2023
DOI:
https://doi.org/10.33321/cdi.2025.49.027Keywords:
rotavirus, gastroenteritis, genotype, surveillance, Australia, vaccine, G3P(8), equine-like G3P(8)Abstract
This report from the Australian Rotavirus Surveillance Program describes the circulating rotavirus genotypes identified in children and adults during the period 1 January to 31 December 2023. During this period, 1,942 faecal samples were referred for rotavirus G- and P- genotype analysis; of these samples, 1,781 were confirmed as rotavirus positive. This is the highest number of rotavirus-positive confirmed samples by the Australian Rotavirus Surveillance Program in the past > 20 years of operation of the program. Of these confirmed rotavirus positive samples, 1,554 of 1,781 (87.3%) were identified as wildtype rotavirus, and 226 of 1,781 (12.7%) were identified as the Rotarix vaccine-like strain. G3P[8] was the dominant genotype nationally (n = 1,117/1,554; 71.9%), comprised of both human G3P[8] (n = 662/1,554; 42.6%) and the equine-like G3P[8] variant (455/1,554; 29.3%). Other frequently identified genotypes included G2P[4] (n = 146/1,554; 9.4%), G12P[8] (n = 100/1,554; 6.4%), G1P[8] (n = 40/1,554; 2.6%), G9P[4] (n = 32/1,554; 2.1%) and G8P[8] (n = 21/1,554; 1.4%).
Genotype distribution was consistent amongst most jurisdictions, with human G3P[8] and equine-like G3P[8] the two dominant genotypes in all jurisdictions, with the exception of the Northern Territory and Western Australia where G2P[4] (7/103; 6.8%) and G12P[8] (54/241; 22.4%) were the second most dominant genotypes respectively.
Consistent with observations in 2022, a small number of unusual genotypes were identified (n = 42/
1,554; 2.7%), including G2P[8] (n = 18/1,554; 1.2%), and G3P[4] (n = 6/1,554; 0.4%). The high number of rotavirus positive samples received by the program reflected the notifications for rotavirus disease reported to the National Notifiable Disease Surveillance Service. The ability to monitor the genotypes of rotavirus strains causing disease across ages and across jurisdictions provides important data on assessing the performance of the national rotavirus vaccine program and to inform public health interventions during outbreaks. This Australian Rotavirus Surveillance Program also provides important data to monitor annual variations in genotypic patterns and to provide diagnostic laboratories with quality assurance by reporting incidences of wildtype, vaccine-like, or false positive rotavirus results.
Downloads
References
Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172(10):958–65. doi: https://doi.org/10.1001/jamapediatrics.2018.1960.
International Vaccine Access Center (IVAC). VIEW-hub by IVAC. [Website.] Baltimore: Johns Hopkins Bloomberg School of Public Health, IVAC; 2023. [Accessed on 29 APril 2024.] Available from: https://view-hub.org.
Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia’s National Childhood vaccine schedule. Pediatr Infect Dis J. 2011;30(1 Suppl):S25–9. doi: https://doi.org/10.1097/INF.0b013e3181fefdee.
Macartney KK, Porwal M, Dalton D, Cripps T, Maldigri T, Isaacs D et al. Decline in rotavirus hospitalisations following introduction of Australia’s national rotavirus immunisation programme. J Paediatr Child Health. 2011;47(5):266–70. doi: https://doi.org/10.1111/j.1440-1754.2010.01953.x.
Reyes JF, Wood JG, Beutels P, Macartney K, McIntyre P, Menzies R et al. Beyond expectations: post-implementation data shows rotavirus vaccination is likely cost-saving in Australia. Vaccine. 2017;35(2):345–52. doi: https://doi.org/10.1016/j.vaccine.2016.11.056.
Roczo-Farkas S, Kirkwood CD, Cowley D, Barnes GL, Bishop RF, Bogdanovic-Sakran N et al. The impact of rotavirus vaccines on genotype diversity: a comprehensive analysis of 2 decades of Australian surveillance data. J Infect Dis. 2018;218(4):546–54. doi: https://doi.org/10.1093/infdis/jiy197.
Australian Government Department of Health and Aged Care. Clinical update: ATAGI advice on Rotarix® to replace RotaTeq®. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 20 December 2017. Available from: https://beta.health.gov.au/news-and-events/news/clinical-update-atagi-advice-on-rotarixr-to-replace-rotateqr.
Australian Government Department of Health and Aged Care. National Communicable Disease Surveillance Dashboard. [Website.] Canberra: Australian Government Department of Health and Aged Care; 2024. [Accessed on 29 April 2024.] Available from: https://nindss.health.gov.au/pbi-dashboard/.
Desselberger U. Rotaviruses. Virus Res. 2014;190:75–96. doi: https://doi.org/10.1016/j.virusres.2014.06.016.
Bányai K, László B, Duque J, Steele AD, Nelson EA, Gentsch JR et al. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine. 2012;30(Suppl 1):A122–30. doi: https://doi.org/10.1016/j.vaccine.2011.09.111.
Dóró R, László B, Martella V, Leshem E, Gentsch J, Parashar U et al. Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure? Infect Genet Evol. 2014;28:446–61. doi: https://doi.org/10.1016/j.meegid.2014.08.017.
Kondo K, Tsugawa T, Ono M, Ohara T, Fujibayashi S, Tahara Y et al. Clinical and molecular characteristics of human rotavirus G8P[8] outbreak strain, Japan, 2014. Emerg Infect Dis. 2017;23(6):968–72. doi: https://doi.org/10.3201/eid2306.160038.
Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Bányai K, Brister JR et al. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol. 2011;156(8):1397–413. doi: https://doi.org/10.1007/s00705-011-1006-z.
Iturriza-Gómara M, Isherwood B, Desselberger U, Gray J. Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999. J Virol. 2001;75(8):3696–705. doi: https://doi.org/10.1128/JVI.75.8.3696-3705.2001.
Donato CM, Roczo-Farkas S, Kirkwood CD, Barnes GL, Bines JE. Rotavirus disease and genotype diversity in older children and adults in Australia. J Infect Dis. 2022;225(12):2116–26. doi: https://doi.org/10.1093/infdis/jiaa430.
Gómara MI, Cubitt D, Desselberger U, Gray J. Amino acid substitution within the VP7 protein of G2 rotavirus strains associated with failure to serotype. J Clin Microbiol. 2001;39(10):3796–8. doi: https://doi.org/10.1128/JCM.39.10.3796-3798.2001.
Simmonds MK, Armah G, Asmah R, Banerjee I, Damanka S, Esona M et al. New oligonucleotide primers for P-typing of rotavirus strains: strategies for typing previously untypeable strains. J Clin Virol. 2008;42(4):368–73. doi: https://doi.org/10.1016/j.jcv.2008.02.011.
Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol. 1992;30(6):1365–73. doi: https://doi.org/10.1128/jcm.30.6.1365-1373.1992.
Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forrester B et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol. 1990;28(2):276–82. doi: https://doi.org/10.1128/jcm.28.2.276-282.1990.
Donato CM, Ch’ng LS, Boniface KF, Crawford NW, Buttery JP, Lyon M et al. Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination. J Infect Dis. 2012;206(3):377–83. doi: https://doi.org/10.1093/infdis/jis361.
Elschner M, Prudlo J, Hotzel H, Otto P, Sachse K. Nested reverse transcriptase-polymerase chain reaction for the detection of group A rotaviruses. J Vet Med B Infect Dis Vet Public Health. 2002;49(2):77–81. doi: https://doi.org/10.1046/j.1439-0450.2002.00510.x.
Cowley D, Donato CM, Roczo-Farkas S, Kirkwood CD. Emergence of a novel equine-like G3P[8] inter-genogroup reassortant rotavirus strain associated with gastroenteritis in Australian children. J Gen Virol. 2016;97(2):403–10. doi: https://doi.org/10.1099/jgv.0.000352.
Roczo-Farkas S, Kirkwood CD, Bines JE, Australian Rotavirus Surveillance Group. Australian Rotavirus Surveillance Program annual report, 2015. Commun Dis Intell Q Rep. 2016;40(4):E527–38.
Northern Territory Government Department of Health (NT Health). Health Alert: Rotavirus. Darwin: NT Health, Centre for Disease Control. Available from: https://health.nt.gov.au/__data/assets/pdf_file/0013/1216102/health-alert-rotavirus.pdf.
Roczo-Farkas S, Kirkwood CD, Bines JE, Enteric Virus Group. Australian Rotavirus Surveillance Program: Annual Report, 2016. Commun Dis Intell Q Rep. 2017;41(4):E455–71.
Roczo-Farkas S, Cowley D, Bines JE, the Australian Rotavirus Surveillance Group. Australian Rotavirus Surveillance Program: Annual Report, 2017. Commun Dis Intell (2018). 2019;43. doi: https://doi.org/10.33321/cdi.2019.43.28.
Roczo-Farkas S, Bines JE, Australian Rotavirus Surveillance G. Australian Rotavirus Surveillance Program: Annual Report, 2018. Commun Dis Intell (2018). 2021;45. doi: https://doi.org/10.33321/cdi.2021.45.6.
Thomas S, Donato CM, Roczo-Farkas S, Hua J, Bines JE. Australian Rotavirus Surveillance Program: Annual Report, 2019. Commun Dis Intell (2018). 2021;45. doi: https://doi.org/10.33321/cdi.2021.45.4.
Roczo-Farkas S, Thomas S, Donato CM, Bogdanovic-Sakran N, Bines JE. Australian Rotavirus Surveillance Program: Annual Report, 2020. Commun Dis Intell (2018). 2021;45. doi: https://doi.org/10.33321/cdi.2021.45.64.
Roczo-Farkas S, Thomas S, Bogdanovic-Sakran N, Donato CM, Lyons EA, Bines J et al. Australian Rotavirus Surveillance Program: Annual Report, 2021. Commun Dis Intell (2018). 2022;46. doi: https://doi.org/10.33321/cdi.2022.46.75.
Donato CM, Roczo-Farkas S, Thomas S, Bogdanovic-Sakran N, Lyons E, Bines JE. Australian Rotavirus Surveillance Program: Annual Report, 2022. Commun Dis Intell (2018). 2024;48. doi: https://doi.org/10.33321/cdi.2024.48.27.
World Health Organization (WHO). Global rotavirus and pediatric diarrhea surveillance: meeting report, WHO Regional Office for the Western Pacific, Manila, Philippines, 11–13 December 2023. Manila: WHO, Regional Office for the Western Pacific; 2024. Available from: https://iris.who.int/handle/10665/376846.
Whiley DM, Ye S, Tozer S, Clark JE, Bletchly C, Lambert SB et al. Over-diagnosis of rotavirus infection in infants due to detection of vaccine virus. Clin Infect Dis. 2020;71(5):1324–6. doi: https://doi.org/10.1093/cid/ciz1196.
Ye S, Whiley DM, Ware RS, Kirkwood CD, Lambert SB, Grimwood K. Multivalent rotavirus vaccine and wild-type rotavirus strain shedding in Australian infants: a birth cohort study. Clin Infect Dis. 2018;66(9):1411–8. doi: https://doi.org/10.1093/cid/cix1022.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
